1. Home
  2. ENTA vs HELE Comparison

ENTA vs HELE Comparison

Compare ENTA & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.04

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Logo Helen of Troy Limited

HELE

Helen of Troy Limited

HOLD

Current Price

$17.01

Market Cap

436.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
HELE
Founded
1995
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
436.1M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
HELE
Price
$14.04
$17.01
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$20.40
$22.00
AVG Volume (30 Days)
220.0K
788.3K
Earning Date
02-09-2026
01-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,980,000.00
$1,802,156,000.00
Revenue This Year
$0.99
N/A
Revenue Next Year
$0.19
$0.67
P/E Ratio
N/A
N/A
Revenue Growth
0.58
N/A
52 Week Low
$4.09
$16.29
52 Week High
$17.15
$60.42

Technical Indicators

Market Signals
Indicator
ENTA
HELE
Relative Strength Index (RSI) 55.34 39.26
Support Level $13.18 $17.95
Resistance Level $15.55 $19.44
Average True Range (ATR) 0.66 0.98
MACD 0.17 0.05
Stochastic Oscillator 50.00 24.44

Price Performance

Historical Comparison
ENTA
HELE

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: